SG Americas Securities LLC Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

SG Americas Securities LLC lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8,337.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 369,542 shares of the medical device company's stock after purchasing an additional 365,162 shares during the quarter. SG Americas Securities LLC owned 0.18% of Cooper Companies worth $31,171,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the business. OFI Invest Asset Management bought a new position in shares of Cooper Companies during the fourth quarter worth about $34,000. City Holding Co. bought a new position in Cooper Companies in the 1st quarter valued at $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies in the 4th quarter valued at $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after buying an additional 120 shares during the last quarter. Finally, Atala Financial Inc purchased a new position in shares of Cooper Companies during the 4th quarter valued at $51,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 1.7%

Shares of COO stock traded down $1.27 during mid-day trading on Wednesday, hitting $71.42. The company's stock had a trading volume of 2,293,889 shares, compared to its average volume of 1,602,790. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38. The business has a 50-day moving average price of $78.01 and a 200 day moving average price of $86.81. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market cap of $14.28 billion, a price-to-earnings ratio of 36.63, a PEG ratio of 2.25 and a beta of 0.98.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.85 earnings per share. Research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday. BNP Paribas raised Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Piper Sandler reaffirmed an "overweight" rating and issued a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Robert W. Baird lowered their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday, May 30th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $100.38.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.